vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and Editas Medicine, Inc. (EDIT). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $24.7M, roughly 1.3× Editas Medicine, Inc.). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -22.7%, a 30.8% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (4.8% vs -19.2%). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 7.0%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

CHCT vs EDIT — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.3× larger
CHCT
$31.5M
$24.7M
EDIT
Growing faster (revenue YoY)
CHCT
CHCT
+24.0% gap
CHCT
4.8%
-19.2%
EDIT
Higher net margin
CHCT
CHCT
30.8% more per $
CHCT
8.1%
-22.7%
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
7.0%
CHCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CHCT
CHCT
EDIT
EDIT
Revenue
$31.5M
$24.7M
Net Profit
$2.5M
$-5.6M
Gross Margin
Operating Margin
-31.3%
Net Margin
8.1%
-22.7%
Revenue YoY
4.8%
-19.2%
Net Profit YoY
60.2%
87.6%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
EDIT
EDIT
Q1 26
$31.5M
Q4 25
$30.9M
$24.7M
Q3 25
$31.1M
$7.5M
Q2 25
$29.1M
$3.6M
Q1 25
$30.1M
$4.7M
Q4 24
$29.3M
$30.6M
Q3 24
$29.6M
$61.0K
Q2 24
$27.5M
$513.0K
Net Profit
CHCT
CHCT
EDIT
EDIT
Q1 26
$2.5M
Q4 25
$14.4M
$-5.6M
Q3 25
$1.6M
$-25.1M
Q2 25
$-12.6M
$-53.2M
Q1 25
$1.6M
$-76.1M
Q4 24
$1.8M
$-45.4M
Q3 24
$1.7M
$-62.1M
Q2 24
$-10.4M
$-67.6M
Operating Margin
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
-31.3%
Q3 25
-325.4%
Q2 25
-1440.6%
Q1 25
-1635.1%
Q4 24
-152.2%
Q3 24
-107649.2%
Q2 24
-14016.2%
Net Margin
CHCT
CHCT
EDIT
EDIT
Q1 26
8.1%
Q4 25
46.6%
-22.7%
Q3 25
5.3%
-333.0%
Q2 25
-43.2%
-1487.8%
Q1 25
5.3%
-1633.5%
Q4 24
6.3%
-148.3%
Q3 24
5.9%
-101870.5%
Q2 24
-37.9%
-13178.8%
EPS (diluted)
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
$0.52
$0.03
Q3 25
$0.03
$-0.28
Q2 25
$-0.50
$-0.63
Q1 25
$0.03
$-0.92
Q4 24
$0.04
$-0.55
Q3 24
$0.04
$-0.75
Q2 24
$-0.42
$-0.82

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
EDIT
EDIT
Cash + ST InvestmentsLiquidity on hand
$2.6M
$146.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$421.3M
$27.3M
Total Assets
$1.0B
$186.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
EDIT
EDIT
Q1 26
$2.6M
Q4 25
$3.3M
$146.6M
Q3 25
$3.4M
$165.6M
Q2 25
$4.9M
$178.5M
Q1 25
$2.3M
$221.0M
Q4 24
$4.4M
$269.9M
Q3 24
$2.8M
$265.1M
Q2 24
$734.0K
$279.1M
Total Debt
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
$57.4M
Q3 24
$473.7M
Q2 24
$457.6M
Stockholders' Equity
CHCT
CHCT
EDIT
EDIT
Q1 26
$421.3M
Q4 25
$429.4M
$27.3M
Q3 25
$426.8M
$13.5M
Q2 25
$437.8M
$19.2M
Q1 25
$461.3M
$62.4M
Q4 24
$476.0M
$134.3M
Q3 24
$477.2M
$175.6M
Q2 24
$497.8M
$232.0M
Total Assets
CHCT
CHCT
EDIT
EDIT
Q1 26
$1.0B
Q4 25
$990.8M
$186.5M
Q3 25
$987.3M
$201.8M
Q2 25
$966.3M
$210.6M
Q1 25
$985.1M
$263.7M
Q4 24
$992.6M
$341.6M
Q3 24
$981.8M
$327.6M
Q2 24
$983.2M
$384.8M
Debt / Equity
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
0.43×
Q3 24
0.99×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
EDIT
EDIT
Operating Cash FlowLast quarter
$-36.4M
Free Cash FlowOCF − Capex
$-36.4M
FCF MarginFCF / Revenue
-147.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
$56.4M
$-36.4M
Q3 25
$12.7M
$-30.8M
Q2 25
$13.8M
$-50.2M
Q1 25
$14.4M
$-47.8M
Q4 24
$58.9M
$-50.8M
Q3 24
$13.8M
$-52.6M
Q2 24
$16.7M
$-57.1M
Free Cash Flow
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
$35.9M
$-36.4M
Q3 25
$7.6M
$-31.3M
Q2 25
$9.6M
Q1 25
$9.7M
$-47.9M
Q4 24
$34.2M
$-51.3M
Q3 24
$6.7M
$-55.5M
Q2 24
$9.5M
$-60.6M
FCF Margin
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
116.0%
-147.3%
Q3 25
24.6%
-414.6%
Q2 25
32.9%
Q1 25
32.3%
-1028.6%
Q4 24
116.9%
-167.6%
Q3 24
22.5%
-90998.4%
Q2 24
34.7%
-11804.3%
Capex Intensity
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
66.3%
0.2%
Q3 25
16.3%
5.7%
Q2 25
14.5%
0.0%
Q1 25
15.6%
2.4%
Q4 24
84.1%
1.8%
Q3 24
24.2%
4788.5%
Q2 24
26.1%
681.1%
Cash Conversion
CHCT
CHCT
EDIT
EDIT
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons